Teriflunomide is a once-daily oral immunomodulator approved for the treatment of relapsing-remitting multiple sclerosis (RRMS) with a consistent safety profile in clinical trials. We report three cases of multiple teeth loss during teriflunomide treatment.
Teeth loss after teriflunomide treatment: Casual or causal? A short case series / Vacchiano, Veria; Frattaruolo, Nicola; Mancinelli, Luca; Foschi, Matteo; Carotenuto, Antonio; Scandellari, Cinzia; Piattelli, Maurizio; Brescia Morra, Vincenzo; Lugaresi, Alessandra. - In: MULTIPLE SCLEROSIS AND RELATED DISORDERS. - ISSN 2211-0348. - 24:(2018), pp. 120-122-122. [10.1016/j.msard.2018.06.018]
Teeth loss after teriflunomide treatment: Casual or causal? A short case series
FOSCHI, MATTEO;Carotenuto, Antonio;Brescia Morra, Vincenzo;
2018
Abstract
Teriflunomide is a once-daily oral immunomodulator approved for the treatment of relapsing-remitting multiple sclerosis (RRMS) with a consistent safety profile in clinical trials. We report three cases of multiple teeth loss during teriflunomide treatment.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
